Português

Inglês

Home | Site Map | Add to Favorites Link | Send page to a Friend | Contact us

Current projects

P-MAPA and FDA -- Regulatory aspects

Farmabrasilis and Immunotherapeutica, the R&D partner, are preparing two applications for the immunomodulator P-MAPA to be submitted to Food and Drug Administration (FDA)

The Farmabrasilis Infectious Diseases Proposal

Giving contribution to the global fight against AIDS and TB, Farmabrasilis introduce a proposal for the treatment of infectious diseases including TB and strategies to large scale deployment of new medicines, in the Third Stop TB Forum, Rio de Janeiro,2009.

P-MAPA against visceral leishmaniaisis

Evaluation of the proteinaceous aggregate of ammonium and magnesium phospholinoleate-palmitoleate as an immunomodulator for treating visceral leismaniasis symptomatic dogs

Lógica Digital

Privacy Policy | Legal | [email protected] all rights reserved